American International Group, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

American International Group, Inc.

$8.5 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$902.69 - $993.35 $709,514 - $780,773	-786 Reduced 1.99%	38,658 $37.2 Million
Q4 2023 Feb 13, 2024	BUY	$775.18 - $881.7 $31,782 - $36,149	41 Added 0.1%	39,444 $34.6 Million
Q3 2023 Nov 13, 2023	BUY	$692.45 - $844.37 $470,173 - $573,327	679 Added 1.75%	39,403 $32.4 Million
Q2 2023 Aug 04, 2023	BUY	$700.03 - $830.35 $408,817 - $484,924	584 Added 1.53%	38,724 $27.8 Million
Q1 2023 May 12, 2023	BUY	$680.49 - $826.97 $193,259 - $234,859	284 Added 0.75%	38,140 $31.3 Million
Q4 2022 Feb 10, 2023	SELL	$705.89 - $766.39 $2.11 Million - $2.29 Million	-2,990 Reduced 7.32%	37,856 $27.3 Million
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $569,952 - $719,249	-993 Reduced 2.37%	40,846 $28.1 Million
Q2 2022 Aug 12, 2022	SELL	$548.35 - $738.84 $677,760 - $913,206	-1,236 Reduced 2.87%	41,839 $24.7 Million
Q1 2022 May 13, 2022	SELL	$595.12 - $698.43 $498,710 - $585,284	-838 Reduced 1.91%	43,075 $30.1 Million
Q4 2021 Feb 11, 2022	BUY	$543.48 - $670.97 $283,696 - $350,246	522 Added 1.2%	43,913 $27.7 Million
Q3 2021 Nov 12, 2021	SELL	$574.03 - $680.96 $160,728 - $190,668	-280 Reduced 0.64%	43,391 $26.3 Million
Q2 2021 Aug 13, 2021	SELL	$472.8 - $558.54 $739,459 - $873,556	-1,564 Reduced 3.46%	43,671 $24.4 Million
Q1 2021 May 07, 2021	SELL	$446.73 - $548.2 $523,567 - $642,490	-1,172 Reduced 2.53%	45,235 $21.4 Million
Q4 2020 Feb 12, 2021	BUY	$478.3 - $607.98 $1.51 Million - $1.91 Million	3,149 Added 7.28%	46,407 $22.4 Million
Q3 2020 Nov 04, 2020	SELL	$544.75 - $658.21 $2,179 - $2,632	-4 Reduced 0.01%	43,258 $24.2 Million
Q2 2020 Aug 12, 2020	BUY	$493.32 - $643.92 $3.23 Million - $4.22 Million	6,551 Added 17.84%	43,262 $27 Million
Q1 2020 May 04, 2020	SELL	$336.18 - $494.43 $187,588 - $275,891	-558 Reduced 1.5%	36,711 $17.9 Million
Q4 2019 Feb 05, 2020	BUY	$274.13 - $376.51 $276,871 - $380,275	1,010 Added 2.79%	37,269 $14 Million
Q3 2019 Nov 08, 2019	BUY	$273.46 - $318.39 $76,568 - $89,149	280 Added 0.78%	36,259 $10.1 Million
Q2 2019 Aug 13, 2019	SELL	$299.6 - $414.82 $467,675 - $647,534	-1,561 Reduced 4.16%	35,979 $11.3 Million
Q1 2019 May 06, 2019	BUY	$372.08 - $439.57 $61,021 - $72,089	164 Added 0.44%	37,540 $15.4 Million
Q4 2018 Feb 13, 2019	BUY	$335.82 - $403.04 $297,872 - $357,496	887 Added 2.43%	37,376 $14 Million
Q3 2018 Nov 09, 2018	BUY	$351.14 - $408.51 $584,296 - $679,760	1,664 Added 4.78%	36,489 $14.7 Million
Q2 2018 Aug 08, 2018	BUY	$284.6 - $344.99 $11,384 - $13,799	40 Added 0.11%	34,825 $12 Million
Q1 2018 May 07, 2018	BUY	$315.82 - $393.78 $5,053 - $6,300	16 Added 0.05%	34,785 $12 Million
Q4 2017 Feb 09, 2018	BUY	$358.63 - $469.95 $255,703 - $335,074	713 Added 2.09%	34,769 $13.1 Million
Q3 2017 Nov 09, 2017	BUY	$431.38 - $504.0 $14.7 Million - $17.2 Million	34,056	34,056 $15.2 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account